Investigating the causes and treatment of high calcium levels from paraffin oil injections
Official title: Hypercalcemia After Cosmetic Paraffin Oil Injections: Unravelling Etiology, Pathogenesis and Potential Treatments
Run by Herlev Hospital · NCT04265599 · Data updated 2026-11-12
This study looks at the health issues caused by paraffin oil injections to see how they affect people and to help find new treatments for those problems.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Herlev Hospital Academic / other |
| Locations | 1 site (Copenhagen) |
| Status | Recruiting |
| Started | April 30, 2019 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | October 1, 2024 |
| Trial ID | NCT04265599 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have previously received intramuscular injections of paraffin or other oils.
✕Probably not a fit
Patients who have not received intramuscular injections of paraffin or other oils may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to characterize the granulomatous disease caused by intramuscular injections of paraffin oil, focusing on the pathogenesis and natural history of the condition. By understanding these aspects, the study seeks to lay the groundwork for identifying novel treatments that can be tested in future randomized clinical trials. The research will involve collecting data from patients who have previously received such injections to better understand the implications of paraffin oil on health.
Why it matters
Potential benefit: If successful, this study could lead to new treatment options for patients suffering from hypercalcemia and related conditions caused by paraffin oil injections.
How similar studies have gone: While this study explores a specific condition, similar observational studies have provided valuable insights into treatment pathways for related diseases, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * previous intramuscular injection of paraffin or other oil Exclusion Criteria: * none
Where it's running
-
Herlev Hospital
Copenhagen, Denmark Recruiting
Study contacts
- Study coordinator: Ebbe Eldrup, DMSc
- Email: ebbe.eldrup@regionh.dk
- Phone: 800-045-3868
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if empagliflozin or losartan reduce kidney stones in paraffin disease
This study tests whether empagliflozin or losartan can lower the risk of kidney stones in men with paraffin granuloma causing high calcium and kidney issues.
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
Impact of CRRT patterns on calcium levels in patients using citrate anticoagulants
This study is testing how different kidney treatment methods affect calcium levels in patients using a specific blood thinner called citrate.
-
Registry for patients with chronic hypoparathyroidism
This study looks at how living with chronic hypoparathyroidism affects patients' overall health and quality of life over time, by comparing their experiences with those of similar people without the condition.
-
Creating a tool to improve CT imaging decisions for blunt trauma patients
This study is testing a new tool to help doctors decide when CT scans are really needed for patients with blunt trauma to avoid unnecessary radiation and costs.
-
Investigating hypercalcemia caused by paraffin oil injections
This study is trying to understand the health risks of paraffin oil injections in young men, especially how they might cause high calcium levels in the blood.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.